U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07766759) titled 'A Phase 1 Study of FXR0906 in Healthy Adults With or Without Elevated Triglycerides' on July 27.
Brief Summary: This is a phase 1, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics effects of a single dose of FXR0906 injection or placebo in Chinese healthy adult volunteers with or without TG increase.
Study Start Date: Aug. 25
Study Type: INTERVENTIONAL
Condition:
Healthy Adult Volunteers
Intervention:
DRUG: Intervention1: FXR0906 injection
A single dose of FXR0906 (dose 1 ) will be administered on Day 1 by subcutaneous injection
DRUG: Intervention2...